PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Mac…

PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine ...
Medical Xpress

A machine learning model may enable liver cancer risk prediction with routine clinical information

A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...
TMCnet

Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection

Partnership expands access to breakthrough blood-based cancer screening into Superpower's comprehensive health check and personalized plans. SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- Superpower, ...
European Medical Journal

Multicancer Detection Achieved with Single Blood Test

New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.

PinkDx Publishes Groundbreaking Evidence in Endometrial Cancer Detection Using a Simple Vaginal Swab

The Gyne Cancer Company™ — today announced the publication of peer-reviewed evidence demonstrating that molecular signals ...
Sierra Sun Times

UCLA Researchers Develop Low-Cost Blood Test to Detect Multiple Cancers and Other Diseases From a Single Sample

April 9, 2026 - By Denise Heady - UCLA scientists have developed a simple and cost-effective blood test that, in early ...
Science Daily

Goodbye colonoscopy? New stool test detects 90% of colorectal cancers

A breakthrough in microbiome research could change how colorectal cancer is detected—no colonoscopy required. Scientists used AI to map gut bacteria at an unprecedented level of detail, revealing ...
TMCnet

GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide

Integration Will Enable Approximately 450 Health Systems to Access the Galleri Test Results Within Their Existing Patient Portal. Collaboration With Epic Will Allow Clinicians to ...

Helio Genomics Appoints Experienced Healthcare Technology Executive John Doyle to its Board of Directors

IRVINE, Calif., April 7, 2026 /PRNewswire/ -- Helio Genomics, Inc., an AI-powered TechBio company focused on early cancer detection, today announced the appointment of John Doyle to its Board of ...